CLINICAL_TRIALS trial_result · 2026-08-11

Clinical Trial Results: Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2 [Phase 4]

Phase 4 trial results exploring mechanisms of hypotensive response to ARB/NEP inhibition in heart failure patients.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Vanderbilt University Medical Center | Conditions: Heart Failure | Phase 4 | Status: COMPLETED | Results posted: 2026-08-11